# Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Osteoarthritis

> **NCT03602872** · PHASE1 · WITHDRAWN · sponsor: **Clinica Santa Clarita, Mexico**

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **BIOLOGICAL:** Human allogeneic mesenchymal bone marrow derived stem cells

## Key facts

- **NCT ID:** NCT03602872
- **Lead sponsor:** Clinica Santa Clarita, Mexico
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-08
- **Primary completion:** 2020-04
- **Final completion:** 2020-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor to start with different protocol, postponed due to COVID
- **Last updated:** 2020-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03602872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03602872, "Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Osteoarthritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03602872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*